DiaSorin Ireland (formerly Biotrin International) has a history of developing niche Immuno Assays, some of which became best-in-class worldwide from both a quality and commercial standpoint. DiaSorin Ireland's core competencies lie in Product Development, Regulatory compliance, high quality and reliable Manufacturing. These skills are currently being applied to Molecular Diagnostic Product Development and Manufacturing.
31st Dec 18 Source: CRO
31st Dec 17 Source: CRO
- 3 more years available »
883rd in Top Companies
- €20 million
- Colm Healy Vice President}
- 6:20am AIB’s mortgages sale, Brexit warnings and wherefore Ulster Bank?
- 5:01am AIB revives €1bn-plus problem mortgages sale
- 4:52am Version 1 directors share €16.5m dividend as revenues rise
- 4:30am Irish woman appointed deputy president of accounting body ACCA
- 4:15am Government steps up calls for firms to get ready for Brexit